OpenAlex
PricingAboutJobs
Log inGet started
Work

Treatment for liver cancer: From sorafenib to natural products

HTML

Year: 2021
Type: review
Source: European Journal of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2021.113690
Authors: Shuli Man, Chen Luo, Mengyao Yan, Ganggang Zhao, Long Ma, Wenyuan Gao
Institutions: Tianjin University of Science and Technology, China International Science and Technology Cooperation, State Key Laboratory of Food Nutrition and Safety, Tianjin University, Qinghai University for Nationalities
Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: liver cancer, hepatocellular carcinoma, sorafenib, lenvatinib, regorafenib, ramucirumab, cabozantinib, drug resistance, natural products, polyphenols, resveratrol, silibinin, icaritin, saponins, ginsenoside Rg3, irinotecan, berberine, arsenic trioxide, angiogenesis inhibition, anti-metastasis, anti-inflammatory activity, antioxidant activity, structure-activity relationship, combination therapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China
Awards: G5009603443, 基于肿瘤微环境干预的重楼皂苷抗转移性肺癌作用机制及物质基础研究
OpenAlex ID: W3182054210
FWCI: 3.624
Cites: 121
Cited by: 189
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security